These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 3101337

  • 1. Failure to induce puberty in a man with X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism by pulsatile administration of low-dose gonadotropin-releasing hormone.
    Kikuchi K, Kaji M, Momoi T, Mikawa H, Shigematsu Y, Sudo M.
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):153-60. PubMed ID: 3101337
    [Abstract] [Full Text] [Related]

  • 2. Contrasting effects of subcutaneous pulsatile GnRH therapy in congenital adrenal hypoplasia and Kallmann's syndrome.
    Gordon D, Cohen HN, Beastall GH, Hay ID, Thomson JA.
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):597-603. PubMed ID: 6439437
    [Abstract] [Full Text] [Related]

  • 3. Hypogonadotropic hypogonadism: hormonal responses to low dose pulsatile administration of gonadotropin-releasing hormone.
    Valk TW, Corley KP, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1980 Oct; 51(4):730-8. PubMed ID: 6774991
    [Abstract] [Full Text] [Related]

  • 4. Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.
    Partsch CJ, Hermanussen M, Sippell WG.
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1196-203. PubMed ID: 3923024
    [Abstract] [Full Text] [Related]

  • 5. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C, Tso SC, Todd D.
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [Abstract] [Full Text] [Related]

  • 6. Hormonal responses in pubertal males to pulsatile gonadotropin releasing hormone (GnRH) administration.
    Gordon D, Cohen HN, Beastall GH, Perry B, Thomson JA.
    J Endocrinol Invest; 1988 Feb; 11(2):77-83. PubMed ID: 3129488
    [Abstract] [Full Text] [Related]

  • 7. Lack of gonadotropic response to pulsatile gonadotropin-releasing hormone in isolated hypogonadotropic hypogonadism associated to congenital adrenal hypoplasia.
    Bovet P, Reymond MJ, Rey F, Gomez F.
    J Endocrinol Invest; 1988 Mar; 11(3):201-4. PubMed ID: 3286743
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females.
    Seminara SB, Achermann JC, Genel M, Jameson JL, Crowley WF.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4501-9. PubMed ID: 10599709
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hypogonadism in congenital adrenal hypoplasia: evidence for a hypothalamic origin.
    Kruse K, Sippell WG, Schnakenburg KV.
    J Clin Endocrinol Metab; 1984 Jan; 58(1):12-7. PubMed ID: 6417152
    [Abstract] [Full Text] [Related]

  • 12. Pulsatile gonadotropin-releasing hormone therapy in male patients with Kallmann's syndrome or constitutional delay of puberty.
    Happ J, Ditscheid W, Krause U.
    Fertil Steril; 1985 Apr; 43(4):599-608. PubMed ID: 3921412
    [Abstract] [Full Text] [Related]

  • 13. Bioactive follicle-stimulating hormone responses to intravenous gonadotropin-releasing hormone in boys with idiopathic hypogonadotropic hypogonadism.
    Padmanabhan V, Kelch RP, Sonstein J, Foster CM, Beitins IZ.
    J Clin Endocrinol Metab; 1988 Oct; 67(4):793-800. PubMed ID: 3138278
    [Abstract] [Full Text] [Related]

  • 14. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone.
    Hoffman AR, Crowley WF.
    N Engl J Med; 1982 Nov 11; 307(20):1237-41. PubMed ID: 6813732
    [Abstract] [Full Text] [Related]

  • 15. Non-responsiveness of serum gonadotropins and testosterone to pulsatile GnRH in hemochromatosis suggesting a pituitary defect.
    Duranteau L, Chanson P, Blumberg-Tick J, Thomas G, Brailly S, Lubetzki J, Schaison G, Bouchard P.
    Acta Endocrinol (Copenh); 1993 Apr 11; 128(4):351-4. PubMed ID: 8498154
    [Abstract] [Full Text] [Related]

  • 16. Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary.
    Sheckter CB, Matsumoto AM, Bremner WJ.
    J Clin Endocrinol Metab; 1989 Feb 11; 68(2):397-401. PubMed ID: 2493030
    [Abstract] [Full Text] [Related]

  • 17. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb 11; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

  • 18. Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism.
    Szilágyi G, Szabolcs I, Vydra G, Góth M, Irsy G.
    Acta Med Hung; 1984 Feb 11; 41(4):175-83. PubMed ID: 6440114
    [Abstract] [Full Text] [Related]

  • 19. Events surrounding the initiation of puberty with long term subcutaneous pulsatile gonadotropin-releasing hormone in a female patient with Kallman's syndrome.
    Seibel MM, Claman P, Oskowitz SP, McArdle C, Weinstein FG.
    J Clin Endocrinol Metab; 1985 Sep 11; 61(3):575-9. PubMed ID: 3926811
    [Abstract] [Full Text] [Related]

  • 20. Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism.
    Lavoie HB, Martin KA, Taylor E, Crowley WF, Hall JE.
    J Clin Endocrinol Metab; 1998 Jan 11; 83(1):241-7. PubMed ID: 9435449
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.